Trial · NCT01190813
Outcomes43
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 43
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Distribution of Amblyopic Eye Visual Acuity Change From Baseline | 18 weeks after enrollment | The ITT principle was followed. For subjects with no visit in the +/- 1 wk window for the 18-wk visit, data from a visit 14-27 wks after randomization were used, if available. Multiple imputation by the Monte Carlo Markov Chain method was used for missing 18-wk VA outcomes based on tx group, baseline VA, \& VA scores from completed follow-up visits. | participants | NUMBER |
| SECONDARY | Amblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 18 Weeks | 18 weeks after enrollment | The analysis followed the intent-to-treat principle. For missing primary outcome visits (±1 wk), data from a visit 14-27 wks after randomization were used, if available.Multiple imputation(Monte Carlo Markov Chain method) was used for missing 18-wk VA outcomes based on treatment group, baseline VA, and VA scores from completed follow-up visits | participants | NUMBER |
| SECONDARY | Distribution of Amblyopic Eye Visual Acuity at 18 Weeks | 18 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Mean Amblyopic Eye Visual Acuity at 18 Weeks | 18 weeks after enrollment | letters | MEAN | |
| SECONDARY | Amblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 4 Weeks | 4 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 10 Weeks | 10 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 16 Weeks | 16 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopic Eye Visual Acuity Improvement Treatment Group Comparison at 26 Weeks | 26 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopia Resolutionat 4 Weeks | 4 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopia Resolution at 10 Weeks | 10 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopia Resolution at 16 Weeks | 16 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopia Resolution at 18 Weeks | 18 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Amblyopia Resolution at 26 Weeks | 26 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Distribution of Amblyopic Eye Visual Acuity Change From Baseline at 4 Weeks | 4 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Mean Change in Amblyopic Eye Visual Acuity From Baseline at 4 Weeks | 4 weeks after enrollment | letters | MEAN | |
| SECONDARY | Distribution of Amblyopic Eye Visual Acuity Change From Baseline at 10 Weeks | 10 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Mean Change in Amblyopic Eye Visual Acuity From Baseline at 10 Weeks | 10 weeks after enrollment | letters | MEAN | |
| SECONDARY | Distribution of Amblyopic Eye Visual Acuity Change From Baseline at 16 Weeks | 16 weeks after enrollment | participants | NUMBER | |
| SECONDARY | Mean Change in Amblyopic Eye Visual Acuity From Baseline at 16 Weeks | 16 weeks after enrollment | letters | MEAN | |
| SECONDARY | Distribution of Amblyopic Eye Visual Acuity Change From Baseline at 26 Weeks | 26 weeks after enrollment | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01190813/outcomes